Table A1.

Mann–Whitney (with the Bonferroni–Holm correction) p-values of significance for comparisons of the study sample characteristics between the study sample groups: ACS, 50 ACS patients; SCAD, 26 patients with stable CAD; HT, 30 hypertensive patients without CAD; CONTR, 30 healthy controls. LDL, low-density lipoproteins; HDL, high-density lipoproteins; HS, hemolysis score; dCq (miR-23a-3p–miR-451a), Cq difference between miR-23a-3p and miR-451a.

Sample Characteristics	Group Comparison	p-Value
Age	ACS vs. CONTR	0.0000001122
	ACS vs. HT	0.1048233616
	ACS vs. SCAD	0.0839889419
	SCAD vs. CONTR	0.0000000135
	SCAD vs. HT	0.0029000312
	HT vs. CONTR	0.0001067908
Total cholesterol, mmol/L	ACS vs. CONTR	0.1155480592
	ACS vs. HT	0.1449169304
	ACS vs. SCAD	0.0003161259
	SCAD vs. CONTR	0.0000189394
	SCAD vs. HT	0.0012925035
	HT vs. CONTR	0.0104547902
Triglycerides, mmol/L	ACS vs. CONTR	0.0000007239
	ACS vs. HT	0.0071015629
	ACS vs. SCAD	0.0306688370
	SCAD vs. CONTR	0.0000003456
	SCAD vs. HT	0.0005974758
	HT vs. CONTR	0.0053900319
LDL cholesterol, mmol/L	ACS vs. CONTR	0.0002317522
	ACS vs. HT	0.1048233616
	ACS vs. SCAD	0.0053309371
	SCAD vs. CONTR	0.0000022994
	SCAD vs. HT	0.0005974758
	HT vs. CONTR	0.0036770681
HDL cholesterol, mmol/L	ACS vs. CONTR	0.0000001122
	ACS vs. HT	0.0000028800
	ACS vs. SCAD	0.0000276922
	SCAD vs. CONTR	0.0519353179
	SCAD vs. HT	0.0369636147
	HT vs. CONTR	0.4208844542
HS	ACS vs. CONTR	0.3345576652
	ACS vs. HT	0.0364064683
	ACS vs. SCAD	0.1892085639
	SCAD vs. CONTR	0.0519353179
	SCAD vs. HT	0.0012561992
	HT vs. CONTR	0.0921457462
dCq (miR-23a-3p–miR-451a)	ACS vs. CONTR	0.1127677221
	ACS vs. HT	0.0043305646
	ACS vs. SCAD	0.2088928853
	SCAD vs. CONTR	0.3286657605
	SCAD vs. HT	0.0407942838
	HT vs. CONTR	0.0475028521